R Kent Jr McGaughy

CIK 1402856 · last filed 2025-05-29

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$65.09M

Companies

5

Total Filings

46

Lifetime Open-Market Net

$65.78M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
TIL Director 8,218,467 $7.92 $65.09M $9.00M 7 2025-05-29
REATA PHARMACEUTICALS INC (RETA) Delisted Director 0 $172.36 $0 $46.76M 29 2023-09-26
Apollo Endosurgery, Inc. (APEN) Delisted Director 0 $10.00 $0 $10.02M 8 2023-04-04
Apollo Endosurgery, Inc. (LPTN) Delisted Director 36,608 $0 1 2016-12-30
GTOP Director $48.03 $0 1 2007-06-13

Recent Filings · Page 5 of 5

46 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2016-06-30 REATA PHARMACEUTICALS INC (RETA) Delisted Buy (P) +164,600 $3.26M EDGAR
2016-06-28 REATA PHARMACEUTICALS INC (RETA) Delisted Buy (P) +73,403 $1.41M EDGAR
2016-06-08 REATA PHARMACEUTICALS INC (RETA) Delisted Buy (P) +24,220 $425.6K EDGAR
2016-06-03 REATA PHARMACEUTICALS INC (RETA) Delisted Buy (P) +8,035 $107.8K EDGAR
2016-06-01 REATA PHARMACEUTICALS INC (RETA) Delisted Mixed +395,136 $3.19M EDGAR
2007-06-13 GTOP Grant (A) $0 EDGAR
Showing 4146 of 46
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.